Cynthia (Cindy) Collins

C-Suite Healthcare Executive 

Career Highlights

  • CEO, Human Longevity, Inc., a genomics-based, health intelligence company

  • Hired as first non-founder CEO to develop operations and commercial capabilities and prepare for public offering. Company was founded 3 years ago by Craig Venter, Peter Diamandis, and Bob Hariri  

  • Senior healthcare executive with a successful track record with public and private businesses in diagnostics, pharmaceuticals, biotech, life sciences, and medical devices

  • Extensive turn-around and startup experience. Reputation for building world-class teams, leading by example, instilling leadership, driving innovation, establishing and executing effective strategies, and delivering results

  • CEO/GM of General Electric’s Healthcare Cell Therapy Business, Lab Businesses and Clarient Diagnostics

  • President and CEO of GenVec

  • Group Vice President, Cellular Analysis Business of Beckman Coulter

  • President and CEO of Sequoia Pharmaceuticals, Inc.

  • President of Clinical Micro Sensors, Inc.

  • 17 years with Baxter Healthcare in a variety of executive roles, including President of Oncology, Vice President of Strategy and Portfolio Management of BioScience, Vice President & General Manager of Cell Therapies, and Vice President of Business Development of Transfusion Therapies

Education

  • BS, Microbiology: University of Illinois

  • MBA: The University of Chicago Booth School of Business

Connect With Us

Cell One Partners

200 Central Park South

Suite 12Q

New York City, NY 10019

E: info@cellonepartners.com

© 2019 Cell One Partners